PubRank

Adjuvant Chemotherapy for High Post-operative Recurrence Risk Stage pI Lung Adenocarcinoma (ACTPI)

Clinical Trial ID NCT03380468

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03380468

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 38.99
2 Cancer statistics in China, 2015. CA Cancer J Clin 2016 12.92
3 Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008 6.64
4 Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011 3.92
5 The Impact of Visceral Pleural Invasion in Node-Negative Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. Chest 2015 2.14
6 Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 2009 2.08
7 Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 2009 2.08
8 Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer. Ann Thorac Surg 2015 1.44
9 Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 2007 1.15
10 Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. J Clin Oncol 2015 1.08
11 Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer. J Cardiothorac Surg 2013 0.99
12 A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component. J Thorac Oncol 2014 0.95
13 Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection. J Thorac Oncol 2012 0.95
14 The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma. Sci Rep 2014 0.94
15 Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence. J Thorac Dis 2014 0.89
16 Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB. J Cancer Res Clin Oncol 2016 0.85
17 Prognostic impact of vascular and lymphovascular invasion in early lung cancer. Asian Cardiovasc Thorac Ann 2013 0.85
18 Prognostic factors of pathologic stage IB non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2011 0.81
19 Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients. Thorac Cancer 2015 0.77
20 Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer. J Chin Med Assoc 2014 0.76
21 The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas. Onco Targets Ther 2016 0.75
Next 100